Pharmaceutical Executive-10-01-2013

Pharmaceutical Executive

Big Pharma's Newest Cost Center

October 31, 2013

Column

0

0

As the burden of promotional disclosure expands beyond US shores, understanding the rules and then controlling the cost of compliance is a strategic necessity.

Country Report: UAE

October 01, 2013

Country Report

0

0

Rumor has it the BRIC palace is crumbling. Perhaps that's overdramatic, but at the very least the BRIC oven is cooling off. Where to now? The United States and Europe remain in a state of languid stagnation, while Asia and Africa are largely addressing basic healthcare needs with low-cost generic medicine.

Market Access is Dead

October 01, 2013

Column

0

0

Patient access is the new driver of change and progress in healthcare marketing, says a senior industry player in market development.

Field Force Evolution: Adapting to a New Ecosystem

October 01, 2013

Features

0

0

Environmental changes on all sides of professional sale are forcing biopharmaceutical companies to select for new traits in the makeup of the field force function.

Taking Stock: Notes on the Industry Audit

October 01, 2013

From the Editor

0

0

Our October issue highlights a latent threat to Big Pharma: the behavioral mindset that may be best characterized as "ageing in place."